US$ 25.04
glp 1 drugs and vision loss Danny D. | ๐๏ธ Important safety update from the *BMJ*: Emerging evidence regulatory reviews are prompting new warnings about a potential link GLP 1 Blindness Risk |
Description
GLP-1 Agonists in Obesity Treatment For years, GLP-1 drugs sat in the diabetes aisle, quietly helping patients control blood sugar

Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3beta pathway in streptozotocin-induced alzheimer rat model

Its really difficult for these patients to lose weight, but it can provide a cure. According to Falardeau, research has shown that a 6% to 10% reduction of body weight can help patients achieve remission, with GLP-1 receptor agonists showing fantastic results in patients with non-vision-threatening IIH

So well build muscle as we burn lots of fat
J Pharm Sci

doi:10.2337/dc15-0109
